- Home
- News
News & Features
Brains Bioceutical Corp, the Global Leader in Natural Cannabinoid APIs, Introduces Revolutionary Solid THC, Ushering in a New Era of Clinical Research
March 6, 2024
Brains Bioceutical Corp Mon, March 4, 2024 at 10:00 p.m. PST·6 min read Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves
Watch on demand: DSM and Brains Bioceutical present at CT-Cann 2023 Leading Industry Session
March 9, 2023
Gain valuable insights into the early-stage drug development of cannabidiol (CBD) from industry experts Terry O’Regan, President of Brains Bioceutical, and Alexandru Zabara, Innovation Manager
Brains Bio Receives NSF’s First CBD Certification for EU GMP CBD API
January 16, 2023
The independent, third-party certification confirms that the company’s facility and EU GMP CBD products have attained NSF Certified for Sport® certification VANCOUVER, British Columbia, Nov.
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
October 5, 2022
Through its wholly owned subsidiary BSPG Laboratories, Brains Bio’s new facility is set to become a global research center for cannabinoid research, testing, and commercialization